298 related articles for article (PubMed ID: 21112201)
61. Advanced protein glycosylation in diabetes and aging.
Brownlee M
Annu Rev Med; 1995; 46():223-34. PubMed ID: 7598459
[TBL] [Abstract][Full Text] [Related]
62. Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures.
Schmitt A; Bigl K; Meiners I; Schmitt J
Biochim Biophys Acta; 2006 Sep; 1763(9):927-36. PubMed ID: 16942810
[TBL] [Abstract][Full Text] [Related]
63. Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD.
Chen L; Wang T; Guo L; Shen Y; Yang T; Wan C; Liao Z; Xu D; Wen F
Lung; 2014 Apr; 192(2):267-75. PubMed ID: 24535058
[TBL] [Abstract][Full Text] [Related]
64. Inhibitory effect of gallic acid on advanced glycation end products induced up-regulation of inflammatory cytokines and matrix proteins in H9C2 (2-1) cells.
Umadevi S; Gopi V; Vellaichamy E
Cardiovasc Toxicol; 2013 Dec; 13(4):396-405. PubMed ID: 24062022
[TBL] [Abstract][Full Text] [Related]
65. [Biochemical properties and clinical significance of protein glycation products].
Staniszewska M; Gamian A
Postepy Hig Med Dosw; 2003; 57(2):123-47. PubMed ID: 12866352
[TBL] [Abstract][Full Text] [Related]
66. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity.
Gaens KH; Stehouwer CD; Schalkwijk CG
Curr Opin Lipidol; 2013 Feb; 24(1):4-11. PubMed ID: 23298958
[TBL] [Abstract][Full Text] [Related]
67. [Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells].
Kaji Y
Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):691-9. PubMed ID: 16363662
[TBL] [Abstract][Full Text] [Related]
68. AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential.
Piperi C; Goumenos A; Adamopoulos C; Papavassiliou AG
Int J Biochem Cell Biol; 2015 Mar; 60():197-201. PubMed ID: 25603271
[TBL] [Abstract][Full Text] [Related]
69. Protein glycation - Between tissue aging and protection.
Simm A; Müller B; Nass N; Hofmann B; Bushnaq H; Silber RE; Bartling B
Exp Gerontol; 2015 Aug; 68():71-5. PubMed ID: 25536383
[TBL] [Abstract][Full Text] [Related]
70. Decreased cerebrovascular response to CO2 in post-menopausal females with COPD: role of oxidative stress.
Hartmann SE; Pialoux V; Leigh R; Poulin MJ
Eur Respir J; 2012 Dec; 40(6):1354-61. PubMed ID: 22496327
[TBL] [Abstract][Full Text] [Related]
71. The role of advanced glycation end products in retinal ageing and disease.
Glenn JV; Stitt AW
Biochim Biophys Acta; 2009 Oct; 1790(10):1109-16. PubMed ID: 19409449
[TBL] [Abstract][Full Text] [Related]
72. Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective.
Mukhopadhyay S; Mukherjee TK
Biochim Biophys Acta; 2005 Sep; 1745(2):145-55. PubMed ID: 15890418
[TBL] [Abstract][Full Text] [Related]
73. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?
Morbini P; Villa C; Campo I; Zorzetto M; Inghilleri S; Luisetti M
Mod Pathol; 2006 Nov; 19(11):1437-45. PubMed ID: 16941014
[TBL] [Abstract][Full Text] [Related]
74. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
[TBL] [Abstract][Full Text] [Related]
75. Advanced Glycation End Products in the Pathogenesis of Psoriasis.
Papagrigoraki A; Maurelli M; Del Giglio M; Gisondi P; Girolomoni G
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156622
[TBL] [Abstract][Full Text] [Related]
76. Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure.
Lewis JB; Hirschi KM; Arroyo JA; Bikman BT; Kooyman DL; Reynolds PR
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28304347
[TBL] [Abstract][Full Text] [Related]
77. [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].
Nawroth PP; Bierhaus A; Vogel GE; Hofmann MA; Zumbach M; Wahl P; Ziegler R
Med Klin (Munich); 1999 Jan; 94(1):29-38. PubMed ID: 10081287
[TBL] [Abstract][Full Text] [Related]
78. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
Ramasamy R; Vannucci SJ; Yan SS; Herold K; Yan SF; Schmidt AM
Glycobiology; 2005 Jul; 15(7):16R-28R. PubMed ID: 15764591
[TBL] [Abstract][Full Text] [Related]
79. [Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property].
Piwowar A
Pol Merkur Lekarski; 2010 Feb; 28(164):166-9. PubMed ID: 20369749
[TBL] [Abstract][Full Text] [Related]
80. [Glycotoxins and cellular dysfunction. A new mechanism for understanding the preventive effects of lifestyle modifications].
Michalsen A; Bierhaus A; Nawroth PP; Dobos GJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Aug; 49(8):773-9. PubMed ID: 16897151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
